Alba Luengo

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 2

Top Topics

Dna Damage Response

Brain Metastases

Advanced Non Small Cell Lung Cancer

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

Massachusetts Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Massachusetts Institute of Technology

United States

PHD :: Biology

Columbia University School of Engineering and Applied Science

United States

BSC :: Biomedical Engineering

Publications

Nimrat Chatterjee, Matthew A Whitman, Cynthia A Harris, Sophia M Min, Oliver Jonas, Evan C Lien, Alba Luengo, Matthew G Vander Heiden, Jiyong Hong, Pei Zhou, Michael T Hemann, Graham C Walker
REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks. Proceedings of the National Academy of Sciences of the United States of America 117 (46) (2020)
Alba Luengo, Keene L Abbott, Shawn M Davidson, Aaron M Hosios, Brandon Faubert, Sze Ham Chan, Elizaveta Freinkman, Lauren G Zacharias, Thomas P Mathews, Andrew T Chan, Ralph J DeBerardinis, Caroline A Lewis, Matthew G Vander Heiden
Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer. Nature communications 10 (1) (2019)